Objective: NF2-related schwannomatosis (NF2) is characterized by bilateral vestibular schwannomas (VS), often causing severe damage to the bilateral auditory function. Auditory brainstem implantation (ABI) provides hearing-impaired patients with an opportunity to reacquire auditory sensation through electrical stimulation of auditory neurons in the cochlear nucleus. However, ABI is not covered by public health insurance in Japan, leading to a large difference in financial burden compared to cochlear implantation (CI). The aim of the present study was to demonstrate the effectiveness of CI as an alternative to ABI for hearing reacquisition in patients with profound hearing loss caused by VS.
Methods: To investigate the current situation of ABI and CI for hearing reconstruction in VS patients, we conducted a questionnaire survey of 102 facilities in Japan. Based on the responses to the questionnaire, a multicenter research group consisting of otolaryngologists and neurosurgeons was established. We collected detailed data on patients with VS who underwent ABI (n = 7, all NF2) and CI (n = 14 [nine NF2, and five non-NF2]).
Results: Some sense of hearing was obtained in all patients but one with CI indicating the efficacy of CI and ABI for profound hearing loss caused by VS. The mean hearing levels were 45.4 dB HL in the ABI patients and 32.7 dB HL in the CI patients, indicating that CI was effective as an alternative to ABI.
Conclusion: The results of the present study suggest the effectiveness of CI as an alternative to ABI for hearing reacquisition in patients with profound hearing loss caused by VS.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.anl.2024.10.010 | DOI Listing |
Eur Arch Otorhinolaryngol
December 2024
King Abdullah Ear Specialist Center (KAESC), College of Medicine, King Saud University, Riyadh, Saudi Arabia.
Objective: Cochlear nerve deficiency (CND) accounts for about one-third of congenital hearing loss cases and presents several challenges during management. Currently, cochlear implant (CI) and auditory brainstem implants (ABI) represent the primary management options for CND. However, robust evidence on the outcomes of different CND management approaches remains limited.
View Article and Find Full Text PDFCochlear Implants Int
July 2024
Department of Otolaryngology, Hacettepe University Medical Faculty, Ankara, Turkey.
Indian J Otolaryngol Head Neck Surg
December 2024
Department of Speech-Language Sciences, All India Institute of Speech and Hearing, University of Mysore, Manasagangothri, Mysuru, Karnataka 570006 India.
Primary Muscle Tension Dysphonia (MTD) occurs in the absence of structural or neurologic etiologies. Patients with MTD are frequently encountered in clinics and are evaluated using multiple measures of voice evaluation. Studies reporting on the correlation of multiple measures of voice evaluation among individuals with MTD are minimal, which led to this study.
View Article and Find Full Text PDFTher Adv Rare Dis
October 2024
Department of Otorhinolaryngology & HNS, Leiden University Medical Centre, Leiden, The Netherlands.
Here, we describe two congenitally deaf male siblings with the same compound heterozygotic, likely pathogenic mutations in the FGF3 gene, associated with the labyrinthine aplasia, microtia and microdontia (LAMM) syndrome. Both children had bilateral cochleovestibular aplasia, precluding cochlear implantation. The elder brother received an auditory brainstem implant (ABI) with very limited auditory responses.
View Article and Find Full Text PDFAuris Nasus Larynx
December 2024
Department of Neurosurgery, Fukushima Medical University School of Medicine, Japan.
Objective: NF2-related schwannomatosis (NF2) is characterized by bilateral vestibular schwannomas (VS), often causing severe damage to the bilateral auditory function. Auditory brainstem implantation (ABI) provides hearing-impaired patients with an opportunity to reacquire auditory sensation through electrical stimulation of auditory neurons in the cochlear nucleus. However, ABI is not covered by public health insurance in Japan, leading to a large difference in financial burden compared to cochlear implantation (CI).
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!